NEU 1.04% $15.48 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-17

  1. 9 Posts.
    Great!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.